Surgical factors do not impact survival in high-grade serous ovarian carcinoma patients treated with neoadjuvant chemotherapy

被引：1
|
作者：
Stewart, J. M. [1 ,2 ]
Tone, A. A. [2 ]
Bernardini, M. Q. [2 ]
Ferguson, S. E. [2 ]
Dodge, J. [2 ]
Laframboise, S. [2 ]
Murphy, K. J. [2 ]
Rosen, B. P. [2 ]
May, T. [2 ,3 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Impact of neoadjuvant chemotherapy duration on the survival of patients with advanced stage high-grade serous or endometrioid ovarian carcinoma
    Nasioudis, Dimitrios
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Simpkins, Fiona
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S183 - S184
  • [2] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Marchocki, Zibi
    Tone, Alicia
    Virtanen, Carl
    de Borja, Richard
    Clarke, Blaise
    Brown, Theodore
    May, Taymaa
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [3] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Zibi Marchocki
    Alicia Tone
    Carl Virtanen
    Richard de Borja
    Blaise Clarke
    Theodore Brown
    Taymaa May
    Journal of Ovarian Research, 15
  • [4] Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
    Montgomery, A. M.
    Crossman, D. K.
    Yang, E. S.
    Alvarez, R. D.
    Huh, W. K.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 12 - 13
  • [5] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
  • [6] Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma
    Xie, Meng
    Zhang, Xuyin
    Jia, Zhan
    Ren, Yunyun
    Wang, Wenping
    ONCOLOGY LETTERS, 2014, 8 (04) : 1652 - 1656
  • [7] The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
    Yuanming Shen
    Yan Ren
    Kelie Chen
    Yixuan Cen
    Bo Zhang
    Weiguo Lu
    Junfen Xu
    Oncogenesis, 11
  • [8] The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma
    Shen, Yuanming
    Ren, Yan
    Chen, Kelie
    Cen, Yixuan
    Zhang, Bo
    Lu, Weiguo
    Xu, Junfen
    ONCOGENESIS, 2022, 11 (01)
  • [9] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Investigation of intratumoral heterogeneity in high-grade serous ovarian carcinoma amongst treatment naive tumors and tumors treated with neoadjuvant chemotherapy
    Evans, Tarra
    Howitt, Brooke
    Crum, Christopher
    Berkowitz, Ross
    Ng, Shu-Wing
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 590 - 591
12345